Finance

Lists
1OT:FRA
Ovid Therapeutics Inc
€2,18
-0,91%
(-0,020) 1D
1 Okt., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1OT...
Open
€2,16
High
€2,18
Low
€2,16
Mkt. cap
474,57 m
Avg. vol.
2,00
Volume
0,00
52-wk high
€2,52
52-wk low
€0,97
No. of employees
23
Open
€2,16
High
€2,18
Low
€2,16
Mkt. cap
474,57 m
Avg. vol.
2,00
Volume
0,00
52-wk high
€2,52
52-wk low
€0,97
No. of employees
23
News stories
From web sources and news partners
About Ovid Therapeutics Inc
CEO-
Employees23
Founded2014
Headquarters-
Sector-
Websiteovidrx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
132,00 k
718,00 k
-
733,00 k
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5,87 m
6,59 m
11,18 m
9,96 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,78 m
6,42 m
6,66 m
6,17 m
Operating expense
12,66 m
13,01 m
17,85 m
16,13 m
Total operating expenses
12,66 m
13,01 m
17,85 m
16,13 m
Operating income
-12,52 m
-12,29 m
-17,85 m
-15,40 m
Other non operating income
62,00 k
57,00 k
121,00 k
-869,00 k
EBT including unusual items
-12,16 m
9,66 m
-16,99 m
-15,01 m
EBT excluding unusual items
-12,16 m
-11,39 m
-16,99 m
-14,71 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12,16 m
9,66 m
-16,99 m
-15,01 m
Net profit margin
-9 210,61%
1 345,82%
-
-2 047,61%
Earnings per share
-0,17
0,06
-0,12
-0,08
Interest and investment income
303,00 k
847,00 k
737,00 k
1,56 m
Interest expense
-
-
-
-
Net interest expenses
303,00 k
847,00 k
737,00 k
1,56 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-12,51 m
-12,28 m
-17,81 m
-15,38 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme